Pfizer and Schlumberger are January Bounce Candidates

Published on 25 Nov 2024 on Investing.com

Each year, I offer a few January bounce candidates ones that I also think may sustain gains during...

Read the rest of the article

Start tracking your investments with Statfolio

But over the last 5 years, Disney shares are still down 22.5%. Disney isn’t cheap. It has a forwa...

Zacks · via Yahoo Finance 28 Nov 2024

We recently published a list of 8 Most Undervalued Pot Stocks to Buy According to Analysts. In th...

Insider Monkey · via Yahoo Finance 28 Nov 2024

It is not uncommon to see a big share price drop if two large institutional investors try to sell...

Simply Wall St. · via Yahoo Finance 27 Nov 2024

Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...

Zacks · via Yahoo Finance 26 Nov 2024

On Friday, the FDA approved BridgeBio Pharma, Inc.’s (NASDAQ:BBIO) Attruby (acoramidis), an...

Benzinga · via Yahoo Finance 25 Nov 2024

Each year, I offer a few January bounce candidates ones that I also think may sustain gains durin...

Investing.com 25 Nov 2024

Here are five Comeback Candidates for 2024. Pfizer The world's largest pharmaceutical company by...

GuruFocus.com · via Yahoo Finance 25 Nov 2024

Donald Trump’s victory is positive for the stock market. The healthcare sector has underperformed...

247wallst.com 25 Nov 2024

For Immediate Release Chicago, IL – November 21, 2024 – Zacks.com announces the list of Stocks...

Zacks · via Yahoo Finance 21 Nov 2024

Year to date, the three major stock indexes — the Dow, the S&P 500 and the Nasdaq Composite — hav...

Zacks · via Yahoo Finance 20 Nov 2024